ComplianceOnline

FDA Issues Draft Guidance for Increasing Women Representation in Medical Device Clinical Trials

  • By: Staff Editor
  • Date: December 28, 2011
Webinar All Access Pass Subscription Abstract:

The FDA has issued a draft guidance that aims at increasing the representation of women in medical device clinical trials. Aimed at medical device manufacturers and developers, the guidance outlines agency recommendations for designing and conducting device clinical studies that may enhance the enrollment of women in such studies, if appropriate.

This article gives an overview and summary of recommendations included in this FDA draft guidance.
 

Bookmark and Share

Trending Compliance Trainings

Challenges of an Effective Change Control Program
By - Kenneth Christie
On Demand Access Anytime
Implementation and Management of GMP Data Integrity
By - Danielle DeLucy
On Demand Access Anytime
FDA Compliance and Clinical Trial Computer System Validation
By - Carolyn Troiano
On Demand Access Anytime
Biocompatibility Testing; what you need to know
By - Mike Colvin
On Demand Access Anytime
Best Sellers
You Recently Viewed
    Loading